Could high Anti-TG antibodies indicate Hashimoto's or Graves' disease?

High anti-thyroglobulin (Anti-TG) antibodies can indicate autoimmune thyroid diseases like Hashimoto's thyroiditis or Graves' disease. While more common in Hashimoto's, Anti-TG antibodies require additional testing including TPO antibodies and thyroid hormones for accurate diagnosis.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Anti-Thyroglobulin Antibodies

Anti-thyroglobulin antibodies (Anti-TG or TgAb) are autoantibodies that your immune system produces against thyroglobulin, a protein made by your thyroid gland. Thyroglobulin plays a crucial role in producing thyroid hormones T3 and T4, which regulate your metabolism, energy levels, and numerous bodily functions.

When your immune system mistakenly identifies thyroglobulin as a foreign threat, it creates these antibodies to attack it. This autoimmune response can damage your thyroid gland and disrupt normal hormone production. While Anti-TG antibodies can be present in healthy individuals at low levels, elevated levels often signal an underlying autoimmune thyroid condition.

Normal vs. Elevated Anti-TG Levels

Laboratory reference ranges for Anti-TG antibodies can vary, but generally:

Anti-TG Antibody Reference Ranges and Clinical Significance

Anti-TG LevelClassificationClinical SignificanceRecommended Action
<4 IU/mL<4 IU/mLNormalNo autoimmune thyroid diseaseNo specific action needed
4-9 IU/mL4-9 IU/mLBorderlinePossible early autoimmune processMonitor annually with TSH
10-100 IU/mL10-100 IU/mLElevatedLikely autoimmune thyroid diseaseFull thyroid panel every 6 months
>100 IU/mL>100 IU/mLSignificantly elevatedStrong indication of autoimmune thyroid diseaseComprehensive evaluation and treatment

Reference ranges may vary by laboratory. Always interpret results in context with symptoms and other thyroid markers.

  • Normal: Less than 4 IU/mL or less than 20 IU/mL (depending on the lab)
  • Borderline elevated: 4-9 IU/mL or 20-40 IU/mL
  • Significantly elevated: Greater than 9 IU/mL or 40 IU/mL

It's important to note that up to 10% of healthy individuals may have detectable Anti-TG antibodies without thyroid disease. However, higher levels and the presence of symptoms typically warrant further investigation. Understanding your Anti-TG levels in context with other thyroid markers provides the most accurate picture of your thyroid health.

Anti-TG Antibodies in Hashimoto's Thyroiditis

Hashimoto's thyroiditis is the most common cause of elevated Anti-TG antibodies. This autoimmune condition causes chronic inflammation of the thyroid gland, gradually destroying thyroid tissue and leading to hypothyroidism (underactive thyroid). Studies show that approximately 60-80% of people with Hashimoto's have positive Anti-TG antibodies.

How Hashimoto's Develops

In Hashimoto's, your immune system produces both Anti-TG antibodies and anti-thyroid peroxidase (TPO) antibodies. These antibodies work together to attack thyroid tissue, causing:

  • Progressive destruction of thyroid cells
  • Reduced production of thyroid hormones
  • Enlargement of the thyroid gland (goiter) in early stages
  • Eventually, thyroid gland shrinkage and hypothyroidism

The presence of Anti-TG antibodies alone doesn't confirm Hashimoto's diagnosis. Healthcare providers typically look for a combination of elevated antibodies, abnormal TSH levels, and clinical symptoms. Regular monitoring of your thyroid function becomes essential when antibodies are detected, as it can take years for full-blown hypothyroidism to develop.

Anti-TG Antibodies in Graves' Disease

While less common than in Hashimoto's, Anti-TG antibodies can also appear in Graves' disease, an autoimmune condition causing hyperthyroidism (overactive thyroid). Approximately 25-30% of people with Graves' disease test positive for Anti-TG antibodies, though they're rarely the primary diagnostic marker.

Distinguishing Graves' from Hashimoto's

Graves' disease has a distinct antibody profile that sets it apart from Hashimoto's:

  • TSH receptor antibodies (TRAb) - the hallmark of Graves' disease
  • Thyroid-stimulating immunoglobulins (TSI) - stimulate excess hormone production
  • TPO antibodies - present in about 70% of cases
  • Anti-TG antibodies - present in 25-30% of cases

The key difference is that Graves' antibodies stimulate the thyroid to produce excess hormones, while Hashimoto's antibodies destroy thyroid tissue. This explains why Graves' leads to hyperthyroidism with symptoms like rapid heartbeat, weight loss, and anxiety, while Hashimoto's causes hypothyroidism with fatigue, weight gain, and depression.

Other Conditions Associated with High Anti-TG

Beyond Hashimoto's and Graves' disease, elevated Anti-TG antibodies can occur in several other conditions:

  • Postpartum thyroiditis - affects 5-10% of women after childbirth
  • Subacute thyroiditis - often follows viral infections
  • Thyroid cancer - particularly papillary and follicular types
  • Multinodular goiter - enlarged thyroid with multiple nodules

Non-Thyroid Autoimmune Conditions

Anti-TG antibodies can also appear in other autoimmune diseases, reflecting the interconnected nature of autoimmune conditions:

  • Type 1 diabetes - up to 20% have thyroid antibodies
  • Rheumatoid arthritis
  • Systemic lupus erythematosus
  • Sjögren's syndrome
  • Celiac disease

This overlap explains why people with one autoimmune condition have a higher risk of developing others. If you have elevated Anti-TG antibodies and another autoimmune disease, regular thyroid monitoring becomes even more important.

Comprehensive Testing for Accurate Diagnosis

While Anti-TG antibodies provide valuable information, they're just one piece of the thyroid health puzzle. A comprehensive thyroid panel should include multiple markers to accurately diagnose and monitor autoimmune thyroid conditions.

Essential Thyroid Tests

  1. TSH (Thyroid Stimulating Hormone) - screens for thyroid dysfunction
  2. Free T4 - measures active thyroid hormone
  3. Free T3 - assesses thyroid hormone conversion
  4. TPO antibodies - more specific for autoimmune thyroid disease
  5. Anti-TG antibodies - confirms autoimmune involvement
  6. TSH receptor antibodies - specific for Graves' disease diagnosis

The combination of these tests helps differentiate between Hashimoto's, Graves', and other thyroid conditions. For example, high TSH with positive antibodies suggests Hashimoto's, while low TSH with positive TSH receptor antibodies indicates Graves' disease. Regular monitoring through comprehensive testing allows you to track disease progression and treatment effectiveness.

Treatment Approaches Based on Antibody Results

Treatment for elevated Anti-TG antibodies depends on the underlying condition and whether thyroid function is affected. Not everyone with positive antibodies requires immediate treatment, but monitoring is essential.

When Thyroid Function is Normal

If you have elevated Anti-TG antibodies but normal thyroid hormone levels, your doctor may recommend:

  • Regular monitoring every 6-12 months
  • Lifestyle modifications to reduce inflammation
  • Addressing nutritional deficiencies (selenium, vitamin D, iron)
  • Managing stress through meditation or yoga
  • Anti-inflammatory diet rich in whole foods

Treatment for Hashimoto's with Hypothyroidism

When Anti-TG antibodies are associated with hypothyroidism from Hashimoto's, treatment typically includes:

  • Levothyroxine (synthetic T4) - the standard treatment
  • Combination T4/T3 therapy for some patients
  • Regular dose adjustments based on TSH levels
  • Addressing gut health and food sensitivities
  • Supplementation with selenium, which may reduce antibody levels

Treatment for Graves' Disease

Graves' disease treatment focuses on reducing thyroid hormone production:

  • Anti-thyroid medications (methimazole or PTU)
  • Beta-blockers for symptom management
  • Radioactive iodine therapy
  • Thyroidectomy in severe cases
  • Regular monitoring of antibody levels

Living with Elevated Anti-TG Antibodies

Having elevated Anti-TG antibodies doesn't necessarily mean you'll develop severe thyroid disease. Many people maintain normal thyroid function for years despite positive antibodies. However, proactive management can help preserve thyroid health and prevent progression.

Lifestyle Strategies for Thyroid Health

  1. Optimize nutrition with adequate iodine, selenium, and zinc
  2. Manage stress through regular exercise and relaxation techniques
  3. Ensure quality sleep of 7-9 hours nightly
  4. Avoid excessive soy and raw cruciferous vegetables
  5. Consider gluten elimination if you have celiac disease or sensitivity
  6. Maintain healthy vitamin D levels through sun exposure or supplementation

Research suggests that addressing inflammation through diet and lifestyle changes may help reduce antibody levels in some people. An anti-inflammatory diet emphasizing whole foods, omega-3 fatty acids, and antioxidants supports overall immune function and may benefit thyroid health.

The Importance of Regular Monitoring

Whether you have Hashimoto's, Graves', or simply elevated antibodies without symptoms, regular monitoring is crucial. Thyroid conditions can evolve over time, and early detection of changes allows for timely intervention. Most experts recommend testing every 3-6 months when first diagnosed or if symptoms change, then annually once stable.

Tracking your antibody levels alongside thyroid hormones helps you and your healthcare provider understand disease progression and treatment effectiveness. Some people see antibody levels decrease with treatment, while others maintain elevated levels despite normal thyroid function. The key is understanding your individual pattern and adjusting management accordingly.

Remember that thyroid health is just one component of overall wellness. Addressing thyroid antibodies often requires a comprehensive approach that considers nutrition, stress management, sleep quality, and other health factors. With proper monitoring and management, most people with elevated Anti-TG antibodies can maintain good thyroid function and quality of life.

References

  1. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499.[PubMed][DOI]
  2. McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012;42(2):252-265.[PubMed][DOI]
  3. Sinclair D. Clinical and laboratory aspects of thyroid autoantibodies. Ann Clin Biochem. 2006;43(Pt 3):173-183.[PubMed][DOI]
  4. Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39-51.[PubMed][DOI]
  5. Toulis KA, Anastasilakis AD, Tzellos TG, Goulis DG, Kouvelas D. Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis. Thyroid. 2010;20(10):1163-1173.[PubMed][DOI]
  6. Effraimidis G, Wiersinga WM. Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur J Endocrinol. 2014;170(6):R241-252.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my Anti-TG antibodies at home?

You can test your Anti-TG antibodies at home with SiPhox Health's Ultimate 360 Health Program, which includes comprehensive thyroid testing with TPOAb, TSH, Free T3, and Free T4. For a more focused approach, the Core Health Program offers TSH testing with the option to add the Thyroid+ expansion for complete thyroid antibody testing.

What's the difference between Anti-TG and TPO antibodies?

Anti-TG antibodies target thyroglobulin protein, while TPO antibodies target thyroid peroxidase enzyme. TPO antibodies are more specific for autoimmune thyroid disease and are positive in 90-95% of Hashimoto's cases compared to 60-80% for Anti-TG. Both antibodies can be elevated together, providing stronger evidence of autoimmune thyroid disease.

Can Anti-TG antibodies go away on their own?

Anti-TG antibodies can fluctuate and sometimes decrease over time, especially with treatment and lifestyle modifications. Some studies show that selenium supplementation, stress reduction, and addressing gut health may help lower antibody levels. However, most people with autoimmune thyroid disease will have detectable antibodies long-term, even with normal thyroid function.

Should I avoid gluten if I have high Anti-TG antibodies?

Some people with thyroid antibodies benefit from gluten elimination, particularly those with celiac disease or non-celiac gluten sensitivity. The molecular similarity between gluten and thyroid tissue may trigger cross-reactivity in susceptible individuals. Consider a 3-month gluten-free trial while monitoring antibody levels and symptoms.

What symptoms might I experience with high Anti-TG antibodies?

Symptoms depend on whether thyroid function is affected. With normal thyroid function, you may have no symptoms. If hypothyroidism develops, expect fatigue, weight gain, cold intolerance, dry skin, and brain fog. Some people experience neck discomfort or fullness from thyroid inflammation even with normal hormone levels.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details